johnson johnson innovative medicine formerly janssen pharmaceuticals pharmaceutical company headquartered beerse belgium whollyowned johnson johnson founded paul janssen janssen pharmaceuticals purchased new jerseybased american corporation johnson johnson became part johnson johnson pharmaceutical research development jj prd renamed janssen research development jrd conducts research development activities related wide range human medical disorders including mental illness neurological disorders anesthesia analgesia gastrointestinal disorders fungal infection hivaids allergies cancer janssen orthomcneil pharmaceutical placed orthomcneiljanssen group within johnson johnson company early roots would become janssen pharmaceuticals date back constant janssen father paul janssen acquired right distribute pharmaceutical products richter hungarian pharmaceutical company belgium netherlands belgian congo october founded nv produkten richter turnhout constant janssen acquired old factory building statiestraat turnhout growing company expanded world war ii fourstory building still student paul janssen assisted development paracetamol usp acetaminophen often referred generically trademark tylenol name perdolan would later become wellknown war name company products changed eupharma although company name richter would remain paul janssen founded research laboratory third floor building statiestraat still within richtereupharma company father team developed first drug neomeritine ambucetamide antispasmodic found particularly effective relief menstrual pain april name company changed nv laboratoria pharmaceutica c janssen named constant janssen april company opened new research facility beerse move beerse would completed may research department beerse became separate legal entity nv research laboratorium c janssen october company acquired american corporation johnson johnson negotiations johnson johnson led frans van den bergh head board directors february name changed janssen pharmaceutica nv seat company turnhout also transferred beerse company led paul janssen bob stouthuysen frans van den bergh pharmaceutical production also moved beerse move turnhout completed janssen expanded worldwide company grew size employees worldwide beginning janssen emphasized core activity research development new drugs research department established beerse developed large research campus janssen research foundation jrf founded performs research new drugs beerse laboratories around globe janssen became flemish company largest budget research development beside headquarters beerse research departments pharmaceutical production administrative departments janssen pharmaceutica belgium still offices berchem janssencilag chemical factory geel janssen biotech olen chemical production plant geel makes active ingredients companys medicines first plant new chemical factory plant established geel plant ii opened plant iii plant iv remaining chemical production beerse transferred geel active components manufactured site geel also manufactures twothirds worldwide chemical production pharmaceutical sector johnson johnson center molecular design cmd founded paul janssen paul lewi clinical research nonclinical development become global organization within johnson johnson part research activities transferred united states reorganization research activities johnson johnson pharmaceutical research development jjprd organization research activities janssen research foundation jrf rw johnson pharmaceutical research institute pri united states merged new global research organization new building pharmaceutical development completed beerse new logistics informatics centre opened new site beerse two new research buildings constructed discovery research center drc drug safety evaluation center dsec october paul janssen research center discovery research inaugurated johnson johnson subsidiary centocor became janssen biotech part janssen also johnson johnson acquired crucell assigned janssen acquisition crucell provided janssen disease prevention arm crucell renamed janssen march janssen licensed tipifarnib farnesyl transferase inhibitor kura oncology assume sole responsibility developing commercialising anticancer later month company announced galapagos pharma regained rights antiinflammatory drug candidate well two compounds including firstinclass inhibitor may company launched collaboration macrogenics preclinical cancer treatment deal could net macrogenics september announced janssen teamed biomedical advanced research development authority barda unit us department health human services create pandemic flu vaccines barda giving janssen million first year million five years contract one projects contract development universal flu vaccine intent vaccine would protect people flu march food drug administration approved janssens spravato esketamine nasal spray treatmentresistant major depressive disorder marked first approval new type antidepressant janssen named defendant trial several opioid manufacturers filed new york attorney general letitia company later removed case johnson johnson agreed pay million settlement new york subsidiary janssen biotech inc founded philadelphia centocor biotech inc initial goal developing new diagnostic assays using monoclonal antibody technology centocor transitioned publicly traded early company moved malvern centocor opened overseas plant leiden eighteen years foundation centocor achieved first year operating centocor sold diagnostic division fujirebio centocor became wholly owned subsidiary johnson centocor purchased new manufacturing plant st louis missouri currently opening new manufacturing facility county cork ireland dutch plant expanded substantially million investment additional production facilities opened needed centocor broke new ground advertising releasing innerstate believed first theatrically released documentary film created entirely funded drug company promote remicade centocor inc ortho biotech inc merged form centocor ortho biotech inc june centocor ortho biotech acquired respivert privately held drug discovery company focused developing smallmolecule inhaled therapies treatment pulmonary june centocor ortho biotech changed name janssen biotech inc part global effort unite janssen pharmaceutical companies around world common december company announced would codevelop macrogenics cancer drug candidate targets proteins treating bcell malignant tumours could net macrogenics january company announced would utilise ionis pharmaceuticals formerly isis pharmaceuticals rnatargeting technology discover develop antisense drugs targeting autoimmune disorders gastrointestinal december xbiotech inc announced would sell novel antibody treatment bermekimab neutralizes alpha janssen biotech march us biomedical advanced research development authority barda allocated million jj janssen develop vaccine novel janssen pharmaceuticals first western pharmaceutical company set pharmaceutical factory peoples republic paul janssen met haide born george shafik hatem lebaneseamerican doctor started working china three days meetings two agreed bring modernized pharmaceutical business china deng xiaoping opened china west janssen sent paul appermont joos horsten set janssen signed cooperation contract modernize production old chemical factory city hanzhong shaanxi province factory would soon produce active compound janssen products mebendazole operating xianjanssen pharmaceuticals new large factory opened city xian also shaanxi janssen pharmaceuticals developed brought market new active substances nce wellknown name may differ eight original janssen drugs included model list essential medicines centocor developed first product approved us food drug administration fda diagnostic test used detect rabies viruscitation needed company launched topselling monoclonal antibody remicade infliximab first fda approved indication crohns disease subsequently remicades market expanded approvals rheumatoid arthritis ankylosing spondylitis psoriatic arthritis ulcerative colitis pediatric crohns disease remicade approved plaque psoriasis september centocor also markets reopro abciximab biologic agent indicated adjunct coronary angioplasty ptca us fda approved simponi human monoclonal antibody treatment arthritis codeveloped medarex united states department justice began investigating sales practices surrounding antipsychotic drug risperidone risperdal agency joined whistleblower suit alleging despite warned us food drug administration promote risperdal effective safe elderly patients known associated early death johnson johnson janssen pharmaceuticals paid pharmacists omnicare largest supplier pharmaceuticals nursing homes tens millions dollars bribes kickbacks promote drug physicians unapproved lawsuit resulted provisional settlement totaling omnicare already settled around four states awarded damages louisiana million south carolina million texas million arkansas billion former head sales president janssen alex gorsky according department justice actively involved fraud became ceo johnson johnson httpsenwikipediaorgwikijanssenpharmaceuticals